Marcel M. Verbeek

24.7k total citations · 1 hit paper
294 papers, 12.9k citations indexed

About

Marcel M. Verbeek is a scholar working on Physiology, Neurology and Molecular Biology. According to data from OpenAlex, Marcel M. Verbeek has authored 294 papers receiving a total of 12.9k indexed citations (citations by other indexed papers that have themselves been cited), including 142 papers in Physiology, 126 papers in Neurology and 99 papers in Molecular Biology. Recurrent topics in Marcel M. Verbeek's work include Alzheimer's disease research and treatments (129 papers), Parkinson's Disease Mechanisms and Treatments (50 papers) and Intracerebral and Subarachnoid Hemorrhage Research (44 papers). Marcel M. Verbeek is often cited by papers focused on Alzheimer's disease research and treatments (129 papers), Parkinson's Disease Mechanisms and Treatments (50 papers) and Intracerebral and Subarachnoid Hemorrhage Research (44 papers). Marcel M. Verbeek collaborates with scholars based in Netherlands, United States and Germany. Marcel M. Verbeek's co-authors include Robert M.W. de Waal, Irene Otte‐Höller, H. Bea Kuiperij, Jurgen A.H.R. Claassen, Marcel G. M. Olde Rikkert, Pieter Wesseling, Bastiaan R. Bloem, Rianne A.J. Esselink, Micha M.M. Wilhelmus and Wilson F. Abdo and has published in prestigious journals such as Journal of Neuroscience, The Journal of Immunology and PLoS ONE.

In The Last Decade

Marcel M. Verbeek

288 papers receiving 12.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevalence of cerebral amyloid angiopathy: A systematic review and meta‐analysis

2021 167 citations Lieke Jäkel, Anna M. de Kort et al. Alzheimer s & Dementia profile →

Peers

Countries citing papers authored by Marcel M. Verbeek

Since Specialization

Citations

This map shows the geographic impact of Marcel M. Verbeek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcel M. Verbeek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcel M. Verbeek more than expected).

Fields of papers citing papers by Marcel M. Verbeek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcel M. Verbeek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcel M. Verbeek. The network helps show where Marcel M. Verbeek may publish in the future.

Co-authorship network of co-authors of Marcel M. Verbeek

This figure shows the co-authorship network connecting the top 25 collaborators of Marcel M. Verbeek. A scholar is included among the top collaborators of Marcel M. Verbeek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcel M. Verbeek. Marcel M. Verbeek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Neuropsychiatric symptoms with focus on apathy and irritability in sporadic and hereditary cerebral amyloid angiopathy 2024 ·Alzheimer s Research & Therapy ·(unknown), Anna M. de Kort, (unknown), (unknown), Bob Siegerink, Sabine Voigt, Erik W. van Zwet, (unknown), Emma A. Koemans, (unknown), Roy P. C. Kessels, Huub A. M. Middelkoop, Floris H.B.M. Schreuder, Catharina J.M. Klijn, Marcel M. Verbeek, Gisela M. Terwindt, Ellis S. van Etten, Marieke J.H. Wermer	3
2	Divergent Associations of Slow‐Wave Sleep versus Rapid Eye Movement Sleep with Plasma Amyloid‐Beta 2024 ·Annals of Neurology ·(unknown), Mariana Pereira, (unknown), Frederik D. Weber, (unknown), (unknown), (unknown), David A. Neville, Nadja Klein, Timo de Wolff, (unknown), Iris Kersten, Manfred Uhr, Jurgen A.H.R. Claassen, Axel Steiger, Marcel M. Verbeek, Martin Dresler	10
3	No replicating evidence for anti‐amyloid‐β autoantibodies in cerebral amyloid angiopathy‐related inflammation 2024 ·Annals of Clinical and Translational Neurology ·E. van den Berg, Rian Roelofs, Lieke Jäkel, Steven M. Greenberg, Andreas Charidimou, Ellis S. van Etten, Delphine Boche, Catharina J.M. Klijn, Floris H.B.M. Schreuder, H. Bea Kuiperij, Marcel M. Verbeek	2
4	Full complement activation is associated with capillary cerebral amyloid angiopathy in Alzheimer’s disease. 2023 ·Alzheimer s & Dementia ·David Hondius, Robert Veerhuis, Ka Wan Li, (unknown), H. Bea Kuiperij, Marcel M. Verbeek, August B. Smit, Annemieke J.M. Rozemüller, Jeroen J.M. Hoozemans	0
5	Glycoproteomics in Cerebrospinal Fluid Reveals Brain-Specific Glycosylation Changes 2023 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), Karin Huijben, Fokje Zijlstra, Joannes F.M. Jacobs, Marcel M. Verbeek, Hans J. C. T. Wessels, Dirk J. Lefeber	11
6	Succinic semialdehyde dehydrogenase deficiency in mice and in humans: An untargeted metabolomics perspective 2023 ·Journal of Inherited Metabolic Disease ·(unknown), Udo F. H. Engelke, (unknown), (unknown), Jean‐Baptiste Roullet, Sanne Broekman, Erik de Vrieze, Erwin van Wijk, Mirjam M. C. Wamelink, Rafael Artuch, Ivo Barić, Jona Merx, Thomas J. Boltje, (unknown), Michèl A.A.P. Willemsen, Marcel M. Verbeek, Ron A. Wevers, K. Michael Gibson, Karlien L. M. Coene	3
7	Factors associated with mortality in early stages of parkinsonism 2022 ·npj Parkinson s Disease ·Anouke van Rumund, Rianne A.J. Esselink, (unknown), Markus Otto, Bastiaan R. Bloem, Marcel M. Verbeek	6
8	Serum GFAP differentiates Alzheimer’s disease from frontotemporal dementia and predicts MCI-to-dementia conversion 2022 ·Journal of Neurology Neurosurgery & Psychiatry ·Patrick Oeckl, Sarah Anderl‐Straub, Christine A. F. Von Arnim, Inês Baldeiras, Janine Diehl‐Schmid, Timo Grimmer, Steffen Halbgebauer, Anna M. de Kort, (unknown), Tainá M. Marques, Marion Ortner, Isabel Santana, Petra Steinacker, Marcel M. Verbeek, Alexander E. Volk, Albert C. Ludolph, Markus Otto	64
9	Elevated expression of urokinase plasminogen activator in rodent models and patients with cerebral amyloid angiopathy 2022 ·Neuropathology and Applied Neurobiology ·(unknown), Xiaoyue Zhu, (unknown), Anna M. de Kort, Tainá M. Marques, Iris Kersten, (unknown), Wilson F. Abdo, Floris H.B.M. Schreuder, (unknown), Gisela M. Terwindt, Marieke J.H. Wermer, Steven M. Greenberg, Catharina J.M. Klijn, H. Bea Kuiperij, William E. Van Nostrand, Marcel M. Verbeek	2
10	Peripheral decarboxylase inhibitors paradoxically induce aromatic L-amino acid decarboxylase 2021 ·npj Parkinson s Disease ·Anouke van Rumund, Lukas Pavelka, Rianne A.J. Esselink, (unknown), Ron A. Wevers, Brit Mollenhauer, Rejko Krüger, Bastiaan R. Bloem, Marcel M. Verbeek	16
11	Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer’s disease, but not in cerebral amyloid angiopathy 2021 ·Alzheimer s Research & Therapy ·Anna M. de Kort, H. Bea Kuiperij, Daniel Alcolea, Iris Kersten, Alexandra A. M. Versleijen, Steven M. Greenberg, Erik Stoops, Floris H.B.M. Schreuder, Catharina J.M. Klijn, Alberto Lleó, Jurgen A.H.R. Claassen, Marcel M. Verbeek	6
12	Physiologically based pharmacokinetic/pharmacodynamic model for the prediction of morphine brain disposition and analgesia in adults and children 2021 ·PLoS Computational Biology ·Laurens F. M. Verscheijden, (unknown), Jan J. Koenderink, Ron H.J. Mathijssen, Marcel M. Verbeek, Saskia N. de Wildt, Frans G. M. Rüssel	19
13	Identification of cerebrospinal fluid biomarkers for parkinsonism using a proteomics approach 2021 ·npj Parkinson s Disease ·Tainá M. Marques, Anouke van Rumund, Iris Kersten, Ilona B. Bruinsma, Hans J. C. T. Wessels, Jolein Gloerich, (unknown), Rianne A.J. Esselink, Bastiaan R. Bloem, H. Bea Kuiperij, Marcel M. Verbeek	17
14	Serum NFL discriminates Parkinson disease from atypical parkinsonisms 2019 ·Neurology ·Tainá M. Marques, Anouke van Rumund, Patrick Oeckl, H. Bea Kuiperij, Rianne A.J. Esselink, Bastiaan R. Bloem, Markus Otto, Marcel M. Verbeek	95
15	α‐Synuclein real‐time quaking‐induced conversion in the cerebrospinal fluid of uncertain cases of parkinsonism 2019 ·Annals of Neurology ·Anouke van Rumund, Alison J. E. Green, Graham Fairfoul, Rianne A.J. Esselink, Bastiaan R. Bloem, Marcel M. Verbeek	102
16	C-Reactive Protein, Plasma Amyloid-β Levels, and Their Interaction With Magnetic Resonance Imaging Markers 2018 ·Stroke ·Saima Hilal, M. Arfan Ikram, Marcel M. Verbeek, Oscar H. Franco, Erik Stoops, Hugo Vanderstichele, Wiro J. Niessen, Meike W. Vernooij	48
17	Parkinson’s Disease Diagnostic Observations (PADDO): study rationale and design of a prospective cohort study for early differentiation of parkinsonism 2018 ·BMC Neurology ·Anouke van Rumund, Marjolein B. Aerts, Rianne A.J. Esselink, Frederick J. A. Meijer, Marcel M. Verbeek, Bastiaan R. Bloem	6
18	Conventional 3T brain MRI and diffusion tensor imaging in the diagnostic workup of early stage parkinsonism 2015 ·Neuroradiology ·Frederick J. A. Meijer, Anouke van Rumund, Anil M. Tuladhar, Marjolein B. Aerts, (unknown), Rianne A.J. Esselink, Bastiaan R. Bloem, Marcel M. Verbeek, Bożena Góraj	31
19	Susceptibility-Weighted Imaging Improves the Diagnostic Accuracy of 3T Brain MRI in the Work-Up of Parkinsonism 2014 ·American Journal of Neuroradiology ·Frederick J. A. Meijer, Anouke van Rumund, (unknown), (unknown), (unknown), Rianne A.J. Esselink, B.R. Bloem, Marcel M. Verbeek, Bożena Góraj	42
20	SPAG16 isoform 2 as a novel autoantigen in multiple sclerosis 2011 ·Document Server@UHasselt (UHasselt) ·Klaartje Somers, Jerome J. A. Hendriks, (unknown), Cees Zwanikken, Marcel M. Verbeek, Piet Stinissen, Veerle Somers	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact